Michael May

Michael May, PhD, is president and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM), a Canadian, not-for-profit that develops technologies, launches new companies and catalyzes investment in the field of regenerative medicine, including cell and gene therapy.

Canada’s biomedical brain drain is reversing. Let’s continue that trend

We must look beyond the lab and build a thriving ecosystem to make sure Canadian biomedical treatments are developed here and benefit Canadians.

opinion | BY MICHAEL MAY, ALLISON BROWN | January 8, 2024

Time to go on offence with Canada’s bio-manufacturing strategy

opinion | BY MICHAEL MAY | September 13, 2021